An effective, less disruptive treatment option
The Radixact System® with TomoTherapy® technology maximizes radiation delivered to the target — while minimizing radiation dose to surrounding healthy tissues. The result is highly personalized treatment designed to significantly reduce the risk of the side effects that too often disrupt the lives of patients during and after treatment. Clinical studies support the use of the TomoTherapy System in the treatment of breast cancer and show evidence of excellent tumor control with minimal radiation delivered to surrounding organs at risk (heart, lungs, etc.) and healthy tissues1, 2, 3 The treatment regimens described in the studies reinforce the benefits of the unique capabilities of the TomoTherapy platform and what clinicians and their patients could expect to see with the Radixact System.